Improvement in glycaemic control and reduction in body weight over 52 weeks with dapagliflozin as add-on therapy to metformin plus sulphonylurea

被引：0
|
作者：
Matthaei, S. [1 ]
Bowering, K. [2 ]
Rohwedder, K. [3 ]
Grohl, A. [4 ]
Johnsson, E. [5 ]
机构：
[1] Diabet Zentrum Quakenbruck, Berlin, Germany
[2] Univ Alberta, Edmonton, AB, Canada
[3] AstraZeneca, Wedel, Germany
[4] Aptiv Solut, Cologne, Germany
[5] AstraZeneca, Molndal, Sweden
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
852
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus inadequately controlled with metformin plus sulphonylurea over 52 weeks
    Vercruysse, F.
    Charpentier, G.
    Wilding, J.
    Hollander, P.
    Gonzalez Galvez, G.
    Mathieu, C.
    Usiskin, K.
    Vijapurkar, U.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    DIABETOLOGIA, 2013, 56 : S373 - S373
  • [22] Exenatide once weekly elicits sustained glycaemic control and weight loss over 52 weeks
    Buse, J.
    Drucker, D.
    Taylor, K.
    Kim, T.
    Wilhelm, K.
    Kendall, D.
    Trautmann, M.
    Zhuang, D.
    Porter, L.
    DIABETOLOGIA, 2008, 51 : S67 - S67
  • [23] Effectiveness of triple therapy with dapagliflozin add-on to dual therapy over 52 weeks in patients with uncontrolled type 2 diabetes mellitus in a centre of high complexity, Cali-Colombia
    Bedoya Joaqui, Vanessa
    Buitrago Gomez, Nathalia
    Carvajal Ortiz, Reinaldo
    Osorio Toro, Luis Miguel
    Munoz Lombo, Jenny Patricia
    Salgado Cifuentes, Carlos Alberto
    Morales Garcia, Monica Andrea
    Abreu Lomba, Alin
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (01): : 49 - 59
  • [24] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES CARE, 2015, 38 (11) : 2018 - 2024
  • [25] Combined HbA1c and Weight Reduction Is Achieved More Frequently With Add-On Dapagliflozin than Add-On Glipizide in Patients With Type 2 Diabetes Inadequately Controlled on Metformin
    Rohwedder, Katja
    Nauck, Michael A.
    Duran-Garcia, Santiago
    Hashemi, Mahdi
    Parikh, Shamik J.
    DIABETES, 2013, 62 : A60 - A61
  • [26] Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial
    Kovacs, C. S.
    Seshiah, V.
    Swallow, R.
    Jones, R.
    Rattunde, H.
    Woerle, H. J.
    Broedl, U. C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 147 - 158
  • [27] Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes
    Raccah, Denis
    Gourdy, Pierre
    Sagnard, Luc
    Ceriello, Antonio
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 742 - 748
  • [28] Gemigliptin added to ongoing metformin therapy provides sustained glycaemic control over 52 weeks and was well tolerated in patients with type 2 diabetes
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Ahn, J. Y.
    Bang, K. S.
    Lee, M. K.
    DIABETOLOGIA, 2013, 56 : S52 - S52
  • [29] Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian Emil
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (11) : 2009 - 2017
  • [30] Quality Measure Thresholds with Saxagliptin (SAXA) plus Dapagliflozin (DAPA) Dual Therapy vs. Individual Components as Add-on to Metformin (MET)
    Blonde, Lawrence
    Sheehan, John J.
    Garcia-Sanchez, Ricardo
    Barrett, Yu Chen
    DIABETES, 2015, 64 : A318 - A318
12345